Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 17 results
Author
Title
Type
Year
Filters:
First Letter Of Last Name
is
R
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Rubin MA
,
Chinnaiyan AM
. 2006.
Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer.
.
Lab Invest. 86(11):1099-102.
Rubin MA
. 2012.
ETS rearrangements in prostate cancer.
.
Asian J Androl. 14(3):393-9.
Rubin MA
,
Varambally S
,
Beroukhim R
,
Tomlins SA
,
Rhodes DR
,
Paris PL
,
Hofer MD
,
Storz-Schweizer M
,
Kuefer R
,
Fletcher JA
et al.
. 2004.
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.
.
Cancer Res. 64(11):3814-22.
Rubin MA
. 2008.
Targeted therapy of cancer: new roles for pathologists--prostate cancer.
.
Mod Pathol. 21 Suppl 2:S44-55.
Rubin MA
. 2004.
Using molecular markers to predict outcome.
.
J Urol. 172(5 Pt 2):S18-21;discussionS21-2.
Rubin MA
,
Elemento O
,
Sboner A
,
Imielinski M
,
Pisapia D
,
Fernandes H
,
Zia H
,
Huang L
,
Tavassoli P
,
Kluk M
. 2016.
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretation
.
JAMIA.
Rubin MA
. 2015.
Toward a prostate cancer precision medicine.
.
Urol Oncol. 33(2):73-4.
Rubin MA
,
Bismar TA
,
Andrén O
,
Mucci L
,
Kim R
,
Shen R
,
Ghosh D
,
Wei JT
,
Chinnaiyan AM
,
Adami H-O
et al.
. 2005.
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
.
Cancer Epidemiol Biomarkers Prev. 14(6):1424-32.
Rubin MA
,
Girelli G
,
Demichelis F
. 2016.
Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate Cancer.
.
Eur Urol. 69(4):557-60.
Rubin MA
. 2015.
Health: Make precision medicine work for cancer care.
.
Nature. 520(7547):290-1.
Rubin MA
,
Allory Y
,
Molinié V
,
Leroy X
,
Faucon H
,
Vacherot F
,
Huang W
,
Kuten A
,
Salomon L
,
Rebillard X
et al.
. 2005.
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome.
.
Urology. 66(5):930-4.
Rubin MA
,
Maher CA
,
Chinnaiyan AM
. 2011.
Common gene rearrangements in prostate cancer.
.
J Clin Oncol. 29(27):3659-68.
Rubin MA
,
Zerkowski MP
,
Camp RL
,
Kuefer R
,
Hofer MD
,
Chinnaiyan AM
,
Rimm DL
. 2004.
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
.
Am J Pathol. 164(3):831-40.
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
Rickman DS
,
T Soong D
,
Moss B
,
Mosquera JMiguel
,
Dlabal J
,
Terry S
,
MacDonald TY
,
Tripodi J
,
Bunting K
,
Najfeld V
et al.
. 2012.
Oncogene-mediated alterations in chromatin conformation.
.
Proc Natl Acad Sci U S A. 109(23):9083-8.
Rickman DS
,
Pflueger D
,
Moss B
,
VanDoren VE
,
Chen CX
,
de la Taille A
,
Kuefer R
,
Tewari AK
,
Setlur SR
,
Demichelis F
et al.
. 2009.
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
.
Cancer Res. 69(7):2734-8.
Rickman DS
,
Chen Y-B
,
Banerjee S
,
Pan Y
,
Yu J
,
Vuong T
,
Perner S
,
Lafargue CJ
,
Mertz KD
,
Setlur SR
et al.
. 2010.
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.
.
Neoplasia. 12(12):1031-40.